From www.bloodjournal.org by guest on September 11, 2016. For personal use only.
Perspectives The role of rituximab in adults with warm antibody autoimmune hemolytic anemia Daan Dierickx,1 Alain Kentos,2 and Andre´ Delannoy2 1
Department of Hematology, University Hospitals Leuven, Leuven, Belgium; and 2Department of Hematology, Hopital ˆ de Jolimont, Haine-Saint-Paul, Belgium
Warm antibody hemolytic anemia is the most common form of autoimmune hemolytic anemia. When therapy is needed, corticosteroids remain the cornerstone of initial treatment but are able to cure only a minority of patients (
Perspectives The role of rituximab in adults with warm antibody autoimmune hemolytic anemia Daan Dierickx,1 Alain Kentos,2 and Andre´ Delannoy2 1
Department of Hematology, University Hospitals Leuven, Leuven, Belgium; and 2Department of Hematology, Hopital ˆ de Jolimont, Haine-Saint-Paul, Belgium
Warm antibody hemolytic anemia is the most common form of autoimmune hemolytic anemia. When therapy is needed, corticosteroids remain the cornerstone of initial treatment but are able to cure only a minority of patients (
